Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier J M, Pelletier J P
Rheumatic Disease Unit Research Laboratory, Notre-Dame Hospital Research Center, University of Montreal, Canada.
Lab Invest. 1994 Jun;70(6):807-15.
In an attempt to identify the factor(s) involved in the modulation of the degradative pathway of articular cartilage, we previously reported a possible imbalance between the levels of biologically active forms of metalloproteases and tissue inhibitor of metalloprotease (TIMP) in osteoarthritis (OA) cartilage.
We extended our analysis on the protein level and the synthesis of stromelysin-1, collagenase, TIMP-1, and TIMP-2 in normal, OA, and RA cartilages, and provided information on the synthesis pattern of these proteins in respect to the action of interleukin-1 (IL-1). These protein concentrations were determined by specific sandwich EIA assays.
This study allowed us to establish that the concentration of stromelysin-1 and collagenase is elevated in both OA and rheumatoid arthritis (RA) cartilages when compared with normal, with significantly higher levels of collagenase found in OA (p < 0.0003) and RA (p < 0.0001), and of stromelysin-1 in RA (p < 0.02). In all cases, the level of stromelysin-1 significantly exceeded (a few 100-fold) the collagenase level. The cartilage TIMP-1 level was notably enhanced only in RA, whereas TIMP-2 was increased in both OA and RA cartilage. RA patients with active disease had a higher level of metalloproteases and TIMP than those patients with inactive disease. Moreover, patients taking steroids alone or in combination with methotrexate had a markedly lower metalloprotease level without any changes in the TIMP-1 level. In culture cartilage explants, the synthesis of stromelysin-1 was enhanced in RA cartilage, whereas the level of collagenase was increased both in OA and RA explants. When compared with normal patients, the TIMP-1 synthesis was essentially unchanged in arthritic explants, whereas the level of TIMP-2 was decreased in RA explants when compared to OA. IL-1 induced a statistically significant increased synthesis of metalloproteases with the highest level found in arthritic explants. IL-1 also significantly decreased the TIMP-1 synthesis in OA and RA explants, and the TIMP-2 synthesis in OA.
This study demonstrates that stromelysin-1 is the predominant metalloprotease synthesized in human articular cartilage and that both TIMP-1 and TIMP-2 are present in this tissue. The differential regulation of metalloprotease and TIMP syntheses by IL-1 suggests that this cytokine, during inflammatory conditions, may promote cartilage degradation by creating an imbalance between the level of these enzymes and their inhibitors.
为了确定参与调节关节软骨降解途径的因素,我们之前报道过骨关节炎(OA)软骨中金属蛋白酶生物活性形式与金属蛋白酶组织抑制剂(TIMP)水平之间可能存在失衡。
我们在蛋白质水平上扩展了对正常、OA和类风湿关节炎(RA)软骨中基质溶解素-1、胶原酶、TIMP-1和TIMP-2合成的分析,并提供了这些蛋白质在白细胞介素-1(IL-1)作用下的合成模式信息。这些蛋白质浓度通过特异性夹心酶免疫分析测定。
本研究使我们确定,与正常情况相比,OA和类风湿关节炎(RA)软骨中基质溶解素-1和胶原酶的浓度均升高,OA中胶原酶水平显著更高(p < 0.0003),RA中也更高(p < 0.0001),RA中基质溶解素-1水平也更高(p < 0.02)。在所有情况下,基质溶解素-1水平显著超过(几百倍)胶原酶水平。软骨TIMP-1水平仅在RA中显著升高,而TIMP-2在OA和RA软骨中均升高。患有活动性疾病的RA患者的金属蛋白酶和TIMP水平高于患有非活动性疾病的患者。此外,单独服用或与甲氨蝶呤联合服用类固醇的患者金属蛋白酶水平明显较低,而TIMP-1水平没有任何变化。在培养的软骨外植体中,RA软骨中基质溶解素-1的合成增强,而OA和RA外植体中胶原酶水平均升高。与正常患者相比,关节炎外植体中TIMP-1合成基本不变,而与OA相比,RA外植体中TIMP-2水平降低。IL-1诱导金属蛋白酶合成在统计学上显著增加,在关节炎外植体中水平最高。IL-1还显著降低OA和RA外植体中TIMP-1的合成,以及OA中TIMP-2的合成。
本研究表明,基质溶解素-1是在人类关节软骨中合成的主要金属蛋白酶,且TIMP-1和TIMP-2均存在于该组织中。IL-1对金属蛋白酶和TIMP合成的差异调节表明,在炎症条件下,这种细胞因子可能通过在这些酶及其抑制剂水平之间造成失衡来促进软骨降解。